AstraZeneca Pharma India Ltd. — Capital/Financing Update 2020

Aug 3, 2020

==> picture [524 x 91] intentionally omitted <==

August 3, 2020

The Manager - Listing

National Stock Exchange of India Ltd.

Exchange plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

The Manager - Listing BSE Limited

Corporate Relationship Dept., 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

Dear Sir(s),

Sub: Meeting of the Board of Directors of the Company to be held on Monday, August 10, 2020 – Ref: Scrip Code BSE: 506820, NSE: ASTRAZEN

This is to inform you that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Monday, August 10, 2020 inter alia, to:

• i. consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2020

• ii. consider declaration of an Interim Dividend to the equity shareholders of the Company for the financial year 2020-21

We would also like to inform you that the ‘Trading Window’ remains closed for all Designated Persons, from June 16, 2020 to August 12, 2020 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

We request you to please take the same on record.

Thanking you,

Yours faithfully

For AstraZeneca Pharma India Limited

Digitally signed by PRATAP PRATAP RUDRA RUDRA BHUVANAGIRI BHUVANAGIRI Date: 2020.08.03 19:49:34 +05'30'

Pratap Rudra Company Secretary & Legal Counsel

==> picture [452 x 64] intentionally omitted <==